Jordan Julie
- SEC CIK
- 0001968554
In the past year, 1 open-market sale filing worth $18.1K and no purchases.
Current role at each company
- NGNE Neurogene Inc.Chief Medical Officeras of Mar 30, 2026
- QTTB Q32 Bio Inc.Chief Medical Officeras of Aug 7, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $18.1K
- 1 filing
- Net
- −$18.1K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Jordan Julie as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
NGNE Neurogene Inc.
Chief Medical Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 30, 2026 (view filing) | Mar 26 | 4 days | Jordan JulieChief Medical Officer | SSale | −828 | $21.89 | −$18.1K | −6.2%12.5K after | 10b5-1 |
QTTB Q32 Bio Inc.
Chief Medical Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 7, 2023 (view filing) | Aug 3 | 4 days | Jordan JulieChief Medical Officer | SSale | −1.85K | $1.39 | −$2.58K | −19.8%7.50K after | 3 lots10b5-1 |
| Aug 4, 2023 (view filing) | Aug 2 | 2 days | Jordan JulieChief Medical Officer | SSale | −99 | $1.31 | −$129.69 | −3.5%2.77K after | 10b5-1 |